Confiabilidade da "Entrevista Clínica Estruturada para o DSM-IV - Versão Clínica" traduzida para o português

Del-Ben, Cristina Marta; Vilela, José Antônio Alves; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Labate, Cybelli Morelo; Zuardi, Antônio Waldo

doi:10.1590/s1516-44462001000300008

Cited by 341 publications

(161 citation statements)

References 12 publications

Supporting

Mentioning

125

Contrasting

Unclassified

Order By: Relevance

“…The absence of psychiatric diagnosis was confirmed by the application of the Structured Clinical Interview for DSM-IV (SCID) (First et al, 1997), no patient version, translated and adapted to Portuguese (Del-Ben et al, 2001). The menstrual cycle was characterized by means of a questionnaire specifically developed for this study, when information regarding the duration of the menstrual cycle in the last 3 months, the regularity of the menstrual cycles, and the date of the last period were registered.…”

Section: Clinical Assessmentmentioning

confidence: 99%

A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms

Lovick

Guapo

Anselmo-Franci

et al. 2017

Psychoneuroendocrinology

View full text Add to dashboard Cite

Lovick, T., Guapo, V. G., Amselmo-Franci, J. A., Loureiro, C. M., Faleiros, C. M., Del Ben, C. M., & Brandão, M. L. (2017). A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms. Psychoneuroendocrinology, 75,[86][87][88][89][90] University of Bristol -Explore Bristol Research General rightsThis document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms There is a consensus that the development of premenstrual dysphoric states is related to cyclical change in gonadal hormone secretion during the menstrual cycle.However, results from studies seeking to link symptom severity to luteal phase progesterone concentration have been equivocal. In the present study we evaluated not only the absolute concentrations of progesterone but also the kinetics of the change in progesterone concentration in relation to development of premenstrual symptoms during the last 10 days of the luteal phase in a population of 46 healthy young adult Brazilian women aged 18-39 years, mean 26.5±6.7 years. In participants who developed symptoms of premenstrual distress, daily saliva progesterone concentration remained stable during most of the mid-late luteal phase, before declining sharply during the last 3 days prior to onset of menstruation. In contrast, progesterone concentration in asymptomatic women underwent a gradual decline over the last 8 days prior to menstruation. Neither maximum nor minimum concentrations of progesterone in the two groups were related to the appearance or severity of premenstrual symptoms. We propose that individual differences in the kinetics of progesterone secretion and/or metabolism may confer differential susceptibility to the development of premenstrual syndrome.

show abstract

Section: Clinical Assessmentmentioning

confidence: 99%

A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms

Lovick

Guapo

Anselmo-Franci

et al. 2017

Psychoneuroendocrinology

View full text Add to dashboard Cite

show abstract

“…Na terceira etapa foi feito um estudo de precisão da RAS por meio da avaliação da consistência interna e da confiabilidade teste e reteste com 45 pacientes reavaliados 15 dias após a primeira testagem. 23 . Os pacientes estavam sob tratamento com antipsicóticos de segunda geração em doses estáveis por pelo menos quatro semanas prévias à avaliação.…”

Section: Desenho Do Estudounclassified

Validação da Recovery Assessment Scale (RAS) no Brasil para avaliar a capacidade de superação das pessoas com esquizofrenia

Silva

Berberian

Gadelha

et al. 2017

J. bras. psiquiatr.

View full text Add to dashboard Cite

RESUMOObjetivo: Adaptar para o Brasil e investigar a confiabilidade e validade da Recovery Assessment Scale (RAS) em pessoas com esquizofrenia. Métodos: Etapa 1 -foi realizada tradução profissional para o português, adaptação e retrotradução da RAS. Etapa 2 -estudo-piloto em um grupo de 12 pessoas com esquizofrenia para garantir compreensão dos itens da escala. Etapa 3 -As pessoas com esquizofrenia (N = 104) foram submetidas à versão brasileira da RAS e a instrumentos de funcionalidade, qualidade de vida e sintomas para busca de evidências de validade. Resultados: Os resultados revelaram bons índices de consistência interna e de precisão teste e reteste dos instrumentos. Foram estabelecidas evidências de validade convergente entre a RAS e medidas de qualidade de vida (r = 0,58; p < 0,001), funcionamento ocupacional (r = 0,40; p < 0,001), habilidades de vida independente (r = 0,24; p < 0,02), gravidade (CGI, r = -0,31; p < 0,003) sintomas da esquizofrenia: PANSS total (r = -0,21; p < 0,05), PANSS negativa (r = -0,28; p < 0.007), PANSS positiva (r = -0.08; p = 0,437)] e depressão [Calgary (r = -0,27; p < 0,01)]. A análise fatorial exploratória revelou seis fatores, sendo quatro destes similares a estudos prévios. Conclusão: A partir deste estudo, considerou-se que a palavra "superação" reflete melhor o conceito de "recovery". A versão brasileira da escala RAS é um instrumento válido e reprodutível para aferir a capacidade de "superação" das pessoas com esquizofrenia. ABSTRACTObjective: To adapt and investigate the validity reliability study of the Brazilian version of the Recovery Assessment Scale-RAS in people with schizophrenia. Methods: Stage 1 -professional translation to Portuguese, adaptation, and back-translation of the RAS; Stage 2 -RAS was presented to 12 outpatients with schizophrenia to evaluate if they would be able to understand and respond to the instrument; Stage 3 -patients with schizophrenia (n = 104) were assessed with the Brazilian version of the RAS, functional outcomes measures, quality of life and symptoms scales. Results: Results showed good internal consistency and retest reliability, and convergent validity between the RAS and quality of life measures (r = 0.58;

show abstract

“…The Structured Clinical Interview from the DSM-IV, clinical version (SCID-CV) (12), translated into Portuguese (13,14), was administered for the confirmation of the diagnosis of SAD. Participants who presented other psychiatric disorders were excluded, except for those with past depressive episodes because depression is frequently comorbid with SAD.…”

Section: Participantsmentioning

confidence: 99%

The response of social anxiety disorder patients to threat scenarios differs from that of healthy controls

Mesquita

Shuhama

Osório

et al. 2011

Braz J Med Biol Res

View full text Add to dashboard Cite

Confiabilidade da "Entrevista Clínica Estruturada para o DSM-IV - Versão Clínica" traduzida para o português

Cited by 341 publications

References 12 publications

A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms

A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms

Validação da Recovery Assessment Scale (RAS) no Brasil para avaliar a capacidade de superação das pessoas com esquizofrenia

The response of social anxiety disorder patients to threat scenarios differs from that of healthy controls

Contact Info

Product

Resources

About